The most important areas of regulations and guidelines controlling clinical trials will be covered including: understanding the importance of the EU Clinical Trial Directive; clinical trial authorisations; the increasingly important requirements for running trials in children; requirements for managing investigational medicinal product; legal aspects of clinical trials; pharmacovigilance; data management, GCP requirements; regulatory inspection and more. Topics will also include an update on the latest CT Directive guidelines and other EU Clinical Trial developments.
Related Journals of Regulatory affairs for clinical trails
Clinical Research and Regulatory Affairs, Applied Clinical Research, Clinical Trials and Regulatory Affairs, International Journal of Drug Regulatory Affairs, Applied Clinical Research, Clinical Research and Regulatory Affairs
Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2023: 371
Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2023: 371
Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2023: 370
Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2023: 370
Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2023: 369
Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2023: 369
Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2023: 368
Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2023: 368
Short Communication: Pharmaceutical Regulatory Affairs: Open Access, 2023: 381
Short Communication: Pharmaceutical Regulatory Affairs: Open Access, 2023: 381
Perspective: Pharmaceutical Regulatory Affairs: Open Access, 2023: 380
Perspective: Pharmaceutical Regulatory Affairs: Open Access, 2023: 380
Opinion: Pharmaceutical Regulatory Affairs: Open Access, 2023: 379
Opinion: Pharmaceutical Regulatory Affairs: Open Access, 2023: 379
Brief Report: Pharmaceutical Regulatory Affairs: Open Access, 2023: 378
Brief Report: Pharmaceutical Regulatory Affairs: Open Access, 2023: 378
Commentary: Pharmaceutical Regulatory Affairs: Open Access, 2023: 377
Commentary: Pharmaceutical Regulatory Affairs: Open Access, 2023: 377
Commentary: Pharmaceutical Regulatory Affairs: Open Access, 2023: 376
Commentary: Pharmaceutical Regulatory Affairs: Open Access, 2023: 376
Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2023: 375
Mini Review: Pharmaceutical Regulatory Affairs: Open Access, 2023: 375
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Scientific Tracks Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Scientific Tracks Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report